Clinical Trial Update: Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of KT-301 in subjects with chronic kidney disease stage 4; the study status is suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• KT-301

Snippet

Sponsor: Kibow Pharma | Conditions: Chronic Kidney Disease stage4 | Phase 2 | Status: SUSPENDED